Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
Publication
, Journal Article
Kramer, BS; Birch, R; Gockerman, JP; Greco, A; Prestridge, K
Published in: Cancer Treat Rep
June 1986
Duke Scholars
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
June 1986
Volume
70
Issue
6
Start / End Page
803 / 804
Location
United States
Related Subject Headings
- Naphthacenes
- Middle Aged
- Male
- Lung Neoplasms
- Humans
- Female
- Drug Evaluation
- Clinical Trials as Topic
- Carcinoma, Squamous Cell
- Carcinoma, Small Cell
Citation
APA
Chicago
ICMJE
MLA
NLM
Kramer, B. S., Birch, R., Gockerman, J. P., Greco, A., & Prestridge, K. (1986). Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial. Cancer Treat Rep, 70(6), 803–804.
Kramer, B. S., R. Birch, J. P. Gockerman, A. Greco, and K. Prestridge. “Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.” Cancer Treat Rep 70, no. 6 (June 1986): 803–4.
Kramer BS, Birch R, Gockerman JP, Greco A, Prestridge K. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial. Cancer Treat Rep. 1986 Jun;70(6):803–4.
Kramer, B. S., et al. “Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.” Cancer Treat Rep, vol. 70, no. 6, June 1986, pp. 803–04.
Kramer BS, Birch R, Gockerman JP, Greco A, Prestridge K. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial. Cancer Treat Rep. 1986 Jun;70(6):803–804.
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
June 1986
Volume
70
Issue
6
Start / End Page
803 / 804
Location
United States
Related Subject Headings
- Naphthacenes
- Middle Aged
- Male
- Lung Neoplasms
- Humans
- Female
- Drug Evaluation
- Clinical Trials as Topic
- Carcinoma, Squamous Cell
- Carcinoma, Small Cell